BEHAVIORAL · Unmapped registry intervention
GWDP
Find medicine records ·
Find other trials using this name
Clinical trial
A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE
NCT02824484
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BEHAVIORAL · Unmapped registry intervention
Control
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Colorectal Cancerverified · MONDO: colorectal cancer
Interventions
Sponsors & collaborators
Azienda USL Reggio Emilia - IRCCSlead sponsor
European University of Romecollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02824484 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.